The use of injectable subcutaneous terbutaline and topical nitroglycerin ointment in the treatment of peripheral vasopressor extravasation in 3 dogs
Objective To describe the clinical course and treatment of 3 dogs with peripheral vasopressor extravasation. Case Series Summary Although vasopressor extravasation (VE) is a well‐documented complication in human medicine, literature describing VE and its management in veterinary patients is sparse....
Gespeichert in:
Veröffentlicht in: | Journal of veterinary emergency and critical care (San Antonio, Tex. : 2000) Tex. : 2000), 2024-07, Vol.34 (4), p.393-398 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 398 |
---|---|
container_issue | 4 |
container_start_page | 393 |
container_title | Journal of veterinary emergency and critical care (San Antonio, Tex. : 2000) |
container_volume | 34 |
creator | Lathroum, Chele N. Angulo Bracho, Hernan Lizardo Alessandrino, Kayla M. Walker, Julie M. |
description | Objective
To describe the clinical course and treatment of 3 dogs with peripheral vasopressor extravasation.
Case Series Summary
Although vasopressor extravasation (VE) is a well‐documented complication in human medicine, literature describing VE and its management in veterinary patients is sparse. VE increases patient morbidity by causing local tissue injury and necrosis. The gold standard treatment for VE, phentolamine, has been periodically limited in supply in human medicine and is not consistently available for use in veterinary medicine. An alternative protocol proposed for use in people with VE combines topical nitroglycerin application with subcutaneous terbutaline infiltration. In this report, a treatment protocol utilizing these therapies was used to treat 3 dogs with VE and secondary tissue injury.
New or Unique Information Provided
This report describes 3 cases of VE‐induced tissue injury in dogs. In addition, this report describes the use of perivascular terbutaline infiltration and topical nitroglycerin application as therapeutic management for VE in dogs. |
doi_str_mv | 10.1111/vec.13393 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3082958909</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3082958909</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2503-4224b29c557740480e288676f0d2858b422820d9e62b478edb06caa5c943c5eb3</originalsourceid><addsrcrecordid>eNp1kc1O3DAURi1UxEyBRV-g8rIswvgvib2sRhSQkNgA28h27oBRxk5tZ-i8Rx8YQ6C7emPf63OPZH8IfaPknJa12oE9p5wrfoCWVLRNJQSnX97PquKsoQv0NaVnQqhSNTtCC64Ipw1nS_T37gnwlACHDXb-GWzWZgCcJmOnrD2EKeEM0ZRicB6w9j3OYXRWD9i7HMPjsLcQncfB-bwFn4sG5yLNEfTcKOqxIOMTxDK10ymMEVIKEcOfHHVp6OyCfxvkuA-P6QQdbvSQ4PRjP0b3vy7u1lfVze3l9frnTWVZTXglGBOGKVvXbSuIkASYlE3bbEjPZC1NuZeM9AoaZkQroTeksVrXVgluazD8GP2YvWMMvydIudu6ZGEY5od3nEimaqmIKujZjNoYUoqw6cbotjruO0q6txC6EkL3HkJhv39oJ7OF_h_5-esFWM3Aixtg_39T93CxnpWvWzWTug</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3082958909</pqid></control><display><type>article</type><title>The use of injectable subcutaneous terbutaline and topical nitroglycerin ointment in the treatment of peripheral vasopressor extravasation in 3 dogs</title><source>MEDLINE</source><source>Wiley Journals</source><creator>Lathroum, Chele N. ; Angulo Bracho, Hernan Lizardo ; Alessandrino, Kayla M. ; Walker, Julie M.</creator><creatorcontrib>Lathroum, Chele N. ; Angulo Bracho, Hernan Lizardo ; Alessandrino, Kayla M. ; Walker, Julie M.</creatorcontrib><description>Objective
To describe the clinical course and treatment of 3 dogs with peripheral vasopressor extravasation.
Case Series Summary
Although vasopressor extravasation (VE) is a well‐documented complication in human medicine, literature describing VE and its management in veterinary patients is sparse. VE increases patient morbidity by causing local tissue injury and necrosis. The gold standard treatment for VE, phentolamine, has been periodically limited in supply in human medicine and is not consistently available for use in veterinary medicine. An alternative protocol proposed for use in people with VE combines topical nitroglycerin application with subcutaneous terbutaline infiltration. In this report, a treatment protocol utilizing these therapies was used to treat 3 dogs with VE and secondary tissue injury.
New or Unique Information Provided
This report describes 3 cases of VE‐induced tissue injury in dogs. In addition, this report describes the use of perivascular terbutaline infiltration and topical nitroglycerin application as therapeutic management for VE in dogs.</description><identifier>ISSN: 1479-3261</identifier><identifier>ISSN: 1476-4431</identifier><identifier>EISSN: 1476-4431</identifier><identifier>DOI: 10.1111/vec.13393</identifier><identifier>PMID: 39031632</identifier><language>eng</language><publisher>United States</publisher><subject>Administration, Topical ; Animals ; Dog Diseases - drug therapy ; Dogs ; Extravasation of Diagnostic and Therapeutic Materials - drug therapy ; Extravasation of Diagnostic and Therapeutic Materials - veterinary ; Female ; Injections, Subcutaneous - veterinary ; local tissue injury ; Male ; nitroglycerin ; Nitroglycerin - administration & dosage ; Nitroglycerin - therapeutic use ; noradrenaline ; norepinephrine ; Ointments ; terbutaline ; Terbutaline - administration & dosage ; Terbutaline - therapeutic use ; Vasoconstrictor Agents - administration & dosage ; Vasoconstrictor Agents - therapeutic use ; Vasodilator Agents - administration & dosage ; Vasodilator Agents - therapeutic use</subject><ispartof>Journal of veterinary emergency and critical care (San Antonio, Tex. : 2000), 2024-07, Vol.34 (4), p.393-398</ispartof><rights>2024 The Authors. published by Wiley Periodicals LLC on behalf of Veterinary Emergency and Critical Care Society.</rights><rights>2024 The Authors. Journal of Veterinary Emergency and Critical Care published by Wiley Periodicals LLC on behalf of Veterinary Emergency and Critical Care Society.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2503-4224b29c557740480e288676f0d2858b422820d9e62b478edb06caa5c943c5eb3</cites><orcidid>0000-0003-0265-9047 ; 0000-0003-1386-5153</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fvec.13393$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fvec.13393$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39031632$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lathroum, Chele N.</creatorcontrib><creatorcontrib>Angulo Bracho, Hernan Lizardo</creatorcontrib><creatorcontrib>Alessandrino, Kayla M.</creatorcontrib><creatorcontrib>Walker, Julie M.</creatorcontrib><title>The use of injectable subcutaneous terbutaline and topical nitroglycerin ointment in the treatment of peripheral vasopressor extravasation in 3 dogs</title><title>Journal of veterinary emergency and critical care (San Antonio, Tex. : 2000)</title><addtitle>J Vet Emerg Crit Care (San Antonio)</addtitle><description>Objective
To describe the clinical course and treatment of 3 dogs with peripheral vasopressor extravasation.
Case Series Summary
Although vasopressor extravasation (VE) is a well‐documented complication in human medicine, literature describing VE and its management in veterinary patients is sparse. VE increases patient morbidity by causing local tissue injury and necrosis. The gold standard treatment for VE, phentolamine, has been periodically limited in supply in human medicine and is not consistently available for use in veterinary medicine. An alternative protocol proposed for use in people with VE combines topical nitroglycerin application with subcutaneous terbutaline infiltration. In this report, a treatment protocol utilizing these therapies was used to treat 3 dogs with VE and secondary tissue injury.
New or Unique Information Provided
This report describes 3 cases of VE‐induced tissue injury in dogs. In addition, this report describes the use of perivascular terbutaline infiltration and topical nitroglycerin application as therapeutic management for VE in dogs.</description><subject>Administration, Topical</subject><subject>Animals</subject><subject>Dog Diseases - drug therapy</subject><subject>Dogs</subject><subject>Extravasation of Diagnostic and Therapeutic Materials - drug therapy</subject><subject>Extravasation of Diagnostic and Therapeutic Materials - veterinary</subject><subject>Female</subject><subject>Injections, Subcutaneous - veterinary</subject><subject>local tissue injury</subject><subject>Male</subject><subject>nitroglycerin</subject><subject>Nitroglycerin - administration & dosage</subject><subject>Nitroglycerin - therapeutic use</subject><subject>noradrenaline</subject><subject>norepinephrine</subject><subject>Ointments</subject><subject>terbutaline</subject><subject>Terbutaline - administration & dosage</subject><subject>Terbutaline - therapeutic use</subject><subject>Vasoconstrictor Agents - administration & dosage</subject><subject>Vasoconstrictor Agents - therapeutic use</subject><subject>Vasodilator Agents - administration & dosage</subject><subject>Vasodilator Agents - therapeutic use</subject><issn>1479-3261</issn><issn>1476-4431</issn><issn>1476-4431</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><sourceid>EIF</sourceid><recordid>eNp1kc1O3DAURi1UxEyBRV-g8rIswvgvib2sRhSQkNgA28h27oBRxk5tZ-i8Rx8YQ6C7emPf63OPZH8IfaPknJa12oE9p5wrfoCWVLRNJQSnX97PquKsoQv0NaVnQqhSNTtCC64Ipw1nS_T37gnwlACHDXb-GWzWZgCcJmOnrD2EKeEM0ZRicB6w9j3OYXRWD9i7HMPjsLcQncfB-bwFn4sG5yLNEfTcKOqxIOMTxDK10ymMEVIKEcOfHHVp6OyCfxvkuA-P6QQdbvSQ4PRjP0b3vy7u1lfVze3l9frnTWVZTXglGBOGKVvXbSuIkASYlE3bbEjPZC1NuZeM9AoaZkQroTeksVrXVgluazD8GP2YvWMMvydIudu6ZGEY5od3nEimaqmIKujZjNoYUoqw6cbotjruO0q6txC6EkL3HkJhv39oJ7OF_h_5-esFWM3Aixtg_39T93CxnpWvWzWTug</recordid><startdate>202407</startdate><enddate>202407</enddate><creator>Lathroum, Chele N.</creator><creator>Angulo Bracho, Hernan Lizardo</creator><creator>Alessandrino, Kayla M.</creator><creator>Walker, Julie M.</creator><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-0265-9047</orcidid><orcidid>https://orcid.org/0000-0003-1386-5153</orcidid></search><sort><creationdate>202407</creationdate><title>The use of injectable subcutaneous terbutaline and topical nitroglycerin ointment in the treatment of peripheral vasopressor extravasation in 3 dogs</title><author>Lathroum, Chele N. ; Angulo Bracho, Hernan Lizardo ; Alessandrino, Kayla M. ; Walker, Julie M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2503-4224b29c557740480e288676f0d2858b422820d9e62b478edb06caa5c943c5eb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Administration, Topical</topic><topic>Animals</topic><topic>Dog Diseases - drug therapy</topic><topic>Dogs</topic><topic>Extravasation of Diagnostic and Therapeutic Materials - drug therapy</topic><topic>Extravasation of Diagnostic and Therapeutic Materials - veterinary</topic><topic>Female</topic><topic>Injections, Subcutaneous - veterinary</topic><topic>local tissue injury</topic><topic>Male</topic><topic>nitroglycerin</topic><topic>Nitroglycerin - administration & dosage</topic><topic>Nitroglycerin - therapeutic use</topic><topic>noradrenaline</topic><topic>norepinephrine</topic><topic>Ointments</topic><topic>terbutaline</topic><topic>Terbutaline - administration & dosage</topic><topic>Terbutaline - therapeutic use</topic><topic>Vasoconstrictor Agents - administration & dosage</topic><topic>Vasoconstrictor Agents - therapeutic use</topic><topic>Vasodilator Agents - administration & dosage</topic><topic>Vasodilator Agents - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lathroum, Chele N.</creatorcontrib><creatorcontrib>Angulo Bracho, Hernan Lizardo</creatorcontrib><creatorcontrib>Alessandrino, Kayla M.</creatorcontrib><creatorcontrib>Walker, Julie M.</creatorcontrib><collection>Wiley Online Library (Open Access Collection)</collection><collection>Wiley Online Library (Open Access Collection)</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of veterinary emergency and critical care (San Antonio, Tex. : 2000)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lathroum, Chele N.</au><au>Angulo Bracho, Hernan Lizardo</au><au>Alessandrino, Kayla M.</au><au>Walker, Julie M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The use of injectable subcutaneous terbutaline and topical nitroglycerin ointment in the treatment of peripheral vasopressor extravasation in 3 dogs</atitle><jtitle>Journal of veterinary emergency and critical care (San Antonio, Tex. : 2000)</jtitle><addtitle>J Vet Emerg Crit Care (San Antonio)</addtitle><date>2024-07</date><risdate>2024</risdate><volume>34</volume><issue>4</issue><spage>393</spage><epage>398</epage><pages>393-398</pages><issn>1479-3261</issn><issn>1476-4431</issn><eissn>1476-4431</eissn><abstract>Objective
To describe the clinical course and treatment of 3 dogs with peripheral vasopressor extravasation.
Case Series Summary
Although vasopressor extravasation (VE) is a well‐documented complication in human medicine, literature describing VE and its management in veterinary patients is sparse. VE increases patient morbidity by causing local tissue injury and necrosis. The gold standard treatment for VE, phentolamine, has been periodically limited in supply in human medicine and is not consistently available for use in veterinary medicine. An alternative protocol proposed for use in people with VE combines topical nitroglycerin application with subcutaneous terbutaline infiltration. In this report, a treatment protocol utilizing these therapies was used to treat 3 dogs with VE and secondary tissue injury.
New or Unique Information Provided
This report describes 3 cases of VE‐induced tissue injury in dogs. In addition, this report describes the use of perivascular terbutaline infiltration and topical nitroglycerin application as therapeutic management for VE in dogs.</abstract><cop>United States</cop><pmid>39031632</pmid><doi>10.1111/vec.13393</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0003-0265-9047</orcidid><orcidid>https://orcid.org/0000-0003-1386-5153</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1479-3261 |
ispartof | Journal of veterinary emergency and critical care (San Antonio, Tex. : 2000), 2024-07, Vol.34 (4), p.393-398 |
issn | 1479-3261 1476-4431 1476-4431 |
language | eng |
recordid | cdi_proquest_miscellaneous_3082958909 |
source | MEDLINE; Wiley Journals |
subjects | Administration, Topical Animals Dog Diseases - drug therapy Dogs Extravasation of Diagnostic and Therapeutic Materials - drug therapy Extravasation of Diagnostic and Therapeutic Materials - veterinary Female Injections, Subcutaneous - veterinary local tissue injury Male nitroglycerin Nitroglycerin - administration & dosage Nitroglycerin - therapeutic use noradrenaline norepinephrine Ointments terbutaline Terbutaline - administration & dosage Terbutaline - therapeutic use Vasoconstrictor Agents - administration & dosage Vasoconstrictor Agents - therapeutic use Vasodilator Agents - administration & dosage Vasodilator Agents - therapeutic use |
title | The use of injectable subcutaneous terbutaline and topical nitroglycerin ointment in the treatment of peripheral vasopressor extravasation in 3 dogs |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T00%3A42%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20use%20of%20injectable%20subcutaneous%20terbutaline%20and%20topical%20nitroglycerin%20ointment%20in%20the%20treatment%20of%20peripheral%20vasopressor%20extravasation%20in%203%20dogs&rft.jtitle=Journal%20of%20veterinary%20emergency%20and%20critical%20care%20(San%20Antonio,%20Tex.%20:%202000)&rft.au=Lathroum,%20Chele%20N.&rft.date=2024-07&rft.volume=34&rft.issue=4&rft.spage=393&rft.epage=398&rft.pages=393-398&rft.issn=1479-3261&rft.eissn=1476-4431&rft_id=info:doi/10.1111/vec.13393&rft_dat=%3Cproquest_cross%3E3082958909%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3082958909&rft_id=info:pmid/39031632&rfr_iscdi=true |